The DOSISPHERE-01 Trial

(2:20)

Impact of DOSISPHERE-01 Trial

(1:36)

DOSISPHERE-01: An Innovative Trial Design

(2:54)

The TheraSphere Story w/ Dr. Riad Salem \u0026 Peter Pattison | BackTable Podcast Ep. 265

(1:55)

TheraSphere™ Infusion Training

(23:56)

Simplicit90Y™ Personalized Dosimetry Software Animation

(2:)

TheraSphere™ Y-90 Glass Microspheres: The LEGACY study

(31)

A unique Infusion of Microspheres for Unique Tumors

(1:21)

Nuclear Medicine Dosimetry - The Future's Essential Need

(20:6)

Portal Vein Recan #Recandoit w/ Dr. Riad Salem | BackTable Podcast Ep. 223

(44:41)

Management of Hepatocellular Carcinoma

(2:19:41)

Immunotherapy in HCC w/ Dr. Tyler Sandow, Dr. Edward Kim \u0026 Dr. Terence Gade | BackTable Ep. 402

(1:12:25)

40. Y90 Microspheres: State of the Science - Part 1.By Prof. Dr. Armeen mahvash

(45:47)

Tailoring Radioembolization: Dosimetry \u0026 Beyond | Dr. Susan Shamimi-Noori | PAIRS Presentation

(44:47)

Radioisotopic Targeting of NETs: Lutetium-177 Dotatate and What Does the Future Hold? by Dr.Bushnell

(42:37)

Interventional Oncology: Radioembolization (Y-90)

(26:28)

Radiotherapy as a career option after MBBS | Radiation Oncology | Dr. Rohan Khandelwal

(28:49)

Role of TARE-Y90: Lessons Learned

(29:47)

Treating a Wide Range of Patients

(1:32)

POL9025 Lecture 10. Prof. Manuel Bardies. Relevance of dosimetry in nuclear medicine

(43:56)

Application and Prospect of Y90 Selective Internal Radiotherapy for Liver Cancer

(4:12)

WATCHMAN Patient Story - Putticks

(2:2)

Accelerating tumour treatment with “the one-hour” Y-90

(5:6)

BTG and Northwestern University - Exploring the curative and palliative treatment options for HCC

(6:1econd)

New updates : Radiotheraphy , cancer treatment

(27:51)

Drs. Salem, Goya, \u0026 Singal talk #HepatocellularCarcinoma during #SIR22BOS - https://bit.ly/3tyiBYw

(1:11:48)

Heretics and Heresies l Robert Green Ingersoll

(57:21)

IO Learning Webinar - The TARGET Study

(25:58)

The TARGET Study - TheraSphere™ Y-90 Glass Microspheres

(2:1econd)